Aclaris Therapeutics Inc

NEW
STU:8AT (USA)  
€ 5.3 +0.13 (+2.51%) Sep 2
At Loss
P/B:
6.94
Market Cap:
€ 784.76M ($ 910.11M)
Enterprise V:
€ 705.78M ($ 818.51M)
Volume:
2.29K
Avg Vol (2M):
1.86K
Trade In:
Volume:
2.29K
At Loss

Aclaris Therapeutics Inc (STU:8AT) Dividend

Aclaris Therapeutics Inc (STU:8AT) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -21.8%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:8AT Dividend

Does Aclaris Therapeutics Inc (STU:8AT) pay a dividend?

Aclaris Therapeutics Inc (STU:8AT) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Aclaris Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Aclaris Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -21.8% over the past 3 years.

What are dividend-paying alternatives to Aclaris Therapeutics Inc?

For dividend-paying alternatives in Aclaris Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.